Reporting Manager
Soleus Capital Master Fund, L.P.
Symbol
IMUX
Shares outstanding
123,490,909 shares
Disclosed Ownership
6,792,000 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
19 Feb 2026, 16:30:01 UTC
Date of event
17 Feb 2026

Sponsored

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 5.5% ownership in IMMUNIC, INC. Common Stock, par value $0.0001 per share (IMUX) on 17 Feb 2026."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G for IMMUNIC, INC. Common Stock, par value $0.0001 per share (IMUX).
  • Disclosed ownership: 5.5%.
  • Date of event: 17 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Feb 2026, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 5.5% 6,792,000 0 6,792,000 /s/ Guy Levy Guy Levy/Managing Member